Calithera Biosciences, Inc. CALA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

56/100

3/6 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Calithera Biosciences, Inc. (CALA) .

本页证实的标准:

VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+666566.7%).
分析师共识目标价 $2.00 (+666566.7% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分： 54/100 其中 3/7 项标准通过。

SharesGrow 7-Criteria Score

56/100

SG Score

View full scorecard →

✓

价值

100/100

Price-to-Earnings & upside

Proven by this page

✓

未來

73/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✓

健康

100/100

Debt-to-Equity & liquidity

→ Health

护城河

46/100

→ Income

✗

成长

15/100

→ Income

—

收入

N/A

No coverage

估值概览 — CALA

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-7.94

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

分析师目标价$2.00 (+666566.7%)

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$-31.36	$0.00	$-12.38M	-
2014	$-93.34	$0.00	$-21.71M	-
2015	$-36.18	$0.00	$-32.64M	-
2016	$-39.01	$0.00	$-38M	-
2017	$-16.89	$25.96M	$-27.83M	-107.2%
2018	$-28.12	$22.25M	$-51.47M	-231.3%
2019	$-36.50	$0.00	$-86.35M	-
2020	$-25.73	$0.00	$-88.52M	-
2021	$-44.77	$9.75M	$-165.34M	-1695.8%
2022	$-7.94	$0.00	$-18.87M	-